Today's After-Hours Movers

Minerva Neurosciences, Inc. (NASDAQ: NERV) 27.4% LOWER; Neither dose of MIN-117 tested in this trial showed a statistically significant separation from placebo on the reduction in the symptoms of MDD over the 6-week treatment period as measured by the change in the MADRS. In addition, neither dose showed a statistically significant separation from placebo on the key secondary endpoint, reduction of symptoms of anxiety as measured by Hamilton Anxiety Rating Scale (HAM-A) over the 6-week treatment period. Patients treated with the 2.5 mg dose experienced an improvement of 1.6 points compared to placebo at Week 2 (p 0.029). No other statistically significant separation from placebo on HAM-A was observed.

Ampio Pharmaceuticals (NYSE: AMPE) 15.3% HIGHER; Roth Capital initiates coverage on with a Buy rating and a price target of $4.00.

Herman Miller (NASDAQ: MLHR) 9.4% LOWER; reported Q2 EPS of $0.88, $0.01 better than the analyst estimate of $0.87. Revenue for the quarter came in at $674.2 million versus the consensus estimate of $697.1 million. Herman Miller sees Q3 2020 EPS of $0.68-$0.72, versus the consensus of $0.75. Herman Miller sees Q3 2020 revenue of $672-692 million, versus the consensus of $674.7 million. Axsome Therapeutics, Inc. (NASDAQ: AXSM) 6% HIGHER; intends to offer and sell shares of its common stock, subject to market and other conditions, in an underwritten public offering.

Green Dot Corporation (NYSE: GDOT) 6.6% LOWER; announced the retirement of Green Dot CEO and Founder, Steve Streit. Mr. Streit will also retire from Green Dots Holding Company Board and as Chairman of the Green Dot Bank board. Mr. Streits retirement initiates an orderly management succession and transition process under which Mr. Streit will transition to the role of Chief Innovation Officer as an independent advisor while Green Dot Board Chairman, William I. Jacobs, will serve as interim Chief Executive Officer and J. Christopher Brewster, Chair of the Audit Committee, will serve as interim president. As part of this process, Green Dot CFO, Mark Shifke, will retire concurrent to Mr. Streit and Jess Unruh, Operational Chief Financial Officer and Chief Accounting Officer, will serve as interim Chief Financial Officer. All transitions will become effective on December 31, 2019.

Exicure, Inc. (NASDAQ: XCUR) 5.4% LOWER; announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. In addition, Exicure intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of the shares of its common stock offered in the public offering. All of the shares are being offered by Exicure. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

New Age Beverages (NASDAQ: NBEV) 4.8% HIGHER; Director Timothy Haas bought 100,000 shares on 12/16 at $1.92.

ABM Industries (NYSE: ABM) 4.3% LOWER; reported Q4 EPS of $0.66, $0.04 better than the analyst estimate of $0.62. Revenue for the quarter came in at $1.65 billion versus the consensus estimate of $1.67 billion. ABM Industries sees FY2020 EPS of $1.90-$2.10, versus the consensus of $2.10.

Micron Technology (NASDAQ: MU) 4.2% HIGHER; reported Q1 EPS of $0.48, $0.01 better than the analyst estimate of $0.47. Revenue for the quarter came in at $5.14 billion versus the consensus estimate of $5.01 billion. Micron Technology sees Q2 2020 EPS of $0.35 at mid-point, versus the consensus of $0.41. Micron Technology sees Q2 2020 revenue of $4.5-4.8 billion, versus the consensus of $4.78 billion.

Inovio Pharmaceuticals (NASDAQ: INO) 3.8% HIGHER; Roth Capital initiates coverage on Iwith a Buy rating and a price target of $13.00.

REV Group, Inc. (NYSE: REVG) 3.6% HIGHER; reported Q4 EPS of $0.05, $0.08 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $652.9 million versus the consensus estimate of $631.22 million. REV Group, Inc. sees FY2020 revenue of $2.45-2.6 billion, versus the consensus of $2.41 billion.

Western Digital Corporation (NYSE: WDC) 2.9% HIGHER; up on MU results